BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27918348)

  • 1. Ewing Sarcoma of the Bone With EWS/FLI1 Translocation After Successful Treatment of Primary Osteosarcoma.
    Yodoya N; Iwamoto S; Matsumine A; Azuma E; Toyoda H; Miura Y; Nakatani K; Imai H; Hirayama M; Komada Y
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):6-9. PubMed ID: 27918348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
    Thomson B; Hawkins D; Felgenhauer J; Radich J
    Bone Marrow Transplant; 1999 Sep; 24(5):527-33. PubMed ID: 10482938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturation toward neuronal tissue in a Ewing sarcoma of bone after chemotherapy.
    Salet MC; Vogels R; Brons P; Schreuder B; Flucke U
    Diagn Pathol; 2016 Aug; 11(1):74. PubMed ID: 27506465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Hepatic Ewing Sarcoma With EWS-FLI1 RNA Transcript in a Child.
    Pochon C; Martelli H; Mussini C; Pariente D; Heymann MF; Corradini N
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):411-3. PubMed ID: 25411865
    [No Abstract]   [Full Text] [Related]  

  • 5. Spinal epidural extraskeletal Ewing sarcoma in an adolescent boy: a case report.
    Athanassiadou F; Tragiannidis A; Kourti M; Papageorgiou T; Kotoula V; Kontopoulos V; Christoforidis J
    Pediatr Hematol Oncol; 2006; 23(3):263-7. PubMed ID: 16517542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents.
    Mora J; de Torres C; Parareda A; Torner F; Galván P; Rodríguez E; Cardesa T; Salvador H; Suñol M; Huguet R; Cruz O
    Pediatr Blood Cancer; 2011 Jul; 57(1):69-75. PubMed ID: 21384537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma Development.
    Komura S; Semi K; Itakura F; Shibata H; Ohno T; Hotta A; Woltjen K; Yamamoto T; Akiyama H; Yamada Y
    Stem Cell Reports; 2016 Apr; 6(4):592-606. PubMed ID: 26997645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
    Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
    Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
    Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
    Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of indications and the perspectives of limb salvage surgery in malignant bone tumours in children and youth].
    Wozniak W; Rychlowska M; Kuczabski M; Szafranski A
    Med Wieku Rozwoj; 2000; 4(2 Suppl 2):85-93. PubMed ID: 11178332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
    Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
    Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.
    Giorgi C; Boro A; Rechfeld F; Lopez-Garcia LA; Gierisch ME; Schäfer BW; Niggli FK
    Oncotarget; 2015 Oct; 6(30):28895-910. PubMed ID: 26336820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.
    Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER
    Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking germline and somatic variation in Ewing sarcoma.
    Gomez NC; Davis IJ
    Nat Genet; 2015 Sep; 47(9):964-5. PubMed ID: 26313223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.
    Le Deley MC; Delattre O; Schaefer KL; Burchill SA; Koehler G; Hogendoorn PC; Lion T; Poremba C; Marandet J; Ballet S; Pierron G; Brownhill SC; Nesslböck M; Ranft A; Dirksen U; Oberlin O; Lewis IJ; Craft AW; Jürgens H; Kovar H
    J Clin Oncol; 2010 Apr; 28(12):1982-8. PubMed ID: 20308673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.
    van Doorninck JA; Ji L; Schaub B; Shimada H; Wing MR; Krailo MD; Lessnick SL; Marina N; Triche TJ; Sposto R; Womer RB; Lawlor ER
    J Clin Oncol; 2010 Apr; 28(12):1989-94. PubMed ID: 20308669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case report of a subcutaneous peripheral primitive neuroectodermal tumor].
    Cabrera R; Sánchez P; Rodríguez MA
    Actas Dermosifiliogr; 2008 Sep; 99(7):555-9. PubMed ID: 18682169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
    Uren A; Toretsky JA
    Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
    Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
    Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.